lidocaine has been researched along with masoprocol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dainaka, J; Ichikawa, A; Okada, M; Tomita, K | 1 |
Gerner, P; Haller, I; Hausott, B; Keller, C; Klimaschewski, L; Lirk, P; Tomaselli, B | 1 |
3 other study(ies) available for lidocaine and masoprocol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Calcium dependency of inhibition by arachidonic acid of compound 48/80-induced histamine release from mast cells.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Catechols; Dose-Response Relationship, Drug; Histamine Release; In Vitro Techniques; Lidocaine; Male; Masoprocol; Mast Cells; p-Methoxy-N-methylphenethylamine; Rats; Rats, Inbred Strains | 1984 |
Neurotoxicity of lidocaine involves specific activation of the p38 mitogen-activated protein kinase, but not extracellular signal-regulated or c-jun N-terminal kinases, and is mediated by arachidonic acid metabolites.
Topics: Anesthetics, Local; Animals; Arachidonic Acid; Cells, Cultured; Enzyme Activation; Ganglia, Spinal; JNK Mitogen-Activated Protein Kinases; Lidocaine; Lipoxygenase Inhibitors; MAP Kinase Signaling System; Masoprocol; Neurons; Neurotoxins; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Phenotype; Rats | 2006 |